EBE’s three top-line recommendations for the EU SME definition

The European Biopharmaceutical Enterprises (EBE) has just submitted comments, prepared by its Innovation & Funding Models Working Group, to the European Commission on its review of how small to medium-sized enterprises (SMEs) are defined. This is a welcome opportunity for the biopharmaceutical industry, considering that the SME designation provides our businesses with access to [...]